Home
Public services
Dashboard
Curated content

Companies
Job board
Investors
Funding rounds
Exits
Accelerators
Workspaces
Universities

More organizations

Matching tool
Investment heatmap
Themes

Powered by

dealroom.co

Contact
FAQ
Privacy

Companies
Biogen
Team
Team

Biogen

Innovative therapies worldwide for people living with serious neurological and neurodegenerative diseases.

Launch date

1978

Employees

Market cap

$28.8b

Enterprise valuation

$33.6b (Public information from Sep 2024)

Share price

$201.44 BIIB

Cambridge Massachusetts (HQ)

http://biogen.com

https://twitter.com/biogen https://www.facebook.com/biogen https://www.linkedin.com/company/biogen-

View job openings

Corporate Venture Fund: Biogen Idec New Ventures

Healthcare
biotechnology
deep tech

biotechnology
horizon europe
risk management
oncology
genetics
dna
intellectual property
neurology
genome engineering
autoimmune

Authorizing premium user...